Z16.32

Clinical Causes: Prolonged or repeated use of antifungal medications, which can promote resistance development Inappropriate prescribing or incorrect dosage of antifungal drugs Misuse or non-adherence to prescribed treatment regimens Infection with inherently resistant fungal strains Genetic mutations within fungal populations that confer resistance Environmental exposure to antifungal agents, such as agricultural fungicides, contributing to resistance in environmental fungi

Key Symptoms: Persistent or recurrent fungal infections despite treatment Worsening of infection symptoms over time Limited or no response to standard antifungal therapies Signs of infection that remain unchanged or escalate, including redness, swelling, or pus Potential spread of infection to other areas if resistant fungi are not effectively controlled

Diagnosis Path: Diagnosing antifungal resistance involves a combination of clinical assessment and laboratory testing. Laboratory methods may include culture and sensitivity testing to determine if the fungi are resistant to specific antifungal medications. Molecular testing can identify genetic markers associated with resistance. Healthcare providers may also review the patient's medication history and response to previous treatments to guide diagnosis.

Treatment Protocols: Managing resistance to antifungal drugs typically requires a tailored approach. Options may include using alternative antifungal agents, combination therapy, higher doses within safe limits, or longer durations of treatment. In some cases, removing infected or contaminated materials and addressing underlying conditions that compromise immunity are necessary. Close monitoring and follow-up are essential to assess response and adjust treatment plans as needed.